nejm.org
Bivalent Covid-19 Vaccines — A Cautionary Tale | NEJM
Since the rollout of bivalent vaccine boosters targeting omicron subvariants, research has suggested they don’t elicit superior immune responses as compared with monovalent boosters. What happened?